ストックスクリーナーアプリを入手
5.03
0.59%
-0.03
アフターアワーズ：
5.06
0.03
+0.60%
前日終値:
$5.06
開ける：
$5.08
24時間の取引高:
26,964
Relative Volume:
0.82
時価総額：
$54.52M
収益：
-
当期純損益:
$-33.82M
株価収益率:
-0.1897
EPS:
-26.5174
ネットキャッシュフロー:
$-66.04M
1週間 パフォーマンス:
+1.00%
1か月 パフォーマンス:
+32.37%
6か月 パフォーマンス:
-33.82%
1年 パフォーマンス:
-40.47%
1日の値動き範囲:
$4.78
$5.10
1週間の範囲:
$4.59
$5.10
52週間の値動き範囲:
$2.96
$11.45
Elicio Therapeutics Inc Stock (ELTX) Company Profile
名前
Elicio Therapeutics Inc
セクター
電話
(857) 209-0050
住所
451 D STREET, 5TH FLOOR, BOSTON
Elicio Therapeutics Inc (ELTX) 最新ニュース
Elicio Therapeutics reports inducement grants - TipRanks
Elicio Therapeutics Reports Inducement Grants - GlobeNewswire
Elicio Therapeutics Reports Inducement Grants - EIN News
Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted - The Bakersfield Californian
Elicio Therapeutics Announces Three Upcoming Presentations - GlobeNewswire
Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines - StockTitan
Elicio Therapeutics CFO resigns to pursue new opportunity By Investing.com - Investing.com Australia
Elicio Therapeutics CFO resigns to pursue new opportunity - Investing.com
Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewswire
ELTX Stock Earnings: Elicio Therapeutics Beats EPS for Q2 2024 - InvestorPlace
Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - BioSpace
Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - StockTitan
Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - wallstreet:online
Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note - GlobeNewswire
Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note - Yahoo Finance
Elicio Therapeutics’ US$40 Million ATM and US$11.5 Million Public Offering - Global Legal Chronicle
Therapeutic Vaccine Industry to Witness Massive Growth - openPR
ASCO 2024Chris Haqq - pharmaphorum
Ratios in Focus: Analyzing Elicio Therapeutics Inc. (ELTX)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex
Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday? - MSN
Elicio Therapeutics sets $11.5 million stock offering By Investing.com - Investing.com Australia
Orion Group Holdings inks $30.5M land sale deal By Investing.com - Investing.com
Apple shares target raised, reiterates Outperform on AI potential By Investing.com - Investing.com
Elicio Therapeutics Shares Drop 35% After Public Offering Prices - MarketWatch
Elicio Therapeutics sets $11.5 million stock offering By Investing.com - Investing.com UK
Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday?Elicio Therapeutics (NASDAQ ... - Benzinga
Elicio Therapeutics Prices of $11.5 Million Underwritten Public Offering - citybiz
Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering - GlobeNewswire
Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering - StockTitan
Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today? - InvestorPlace
Elicio Therapeutics launches public offering of stock and warrants By Investing.com - Investing.com Australia
Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday? - Benzinga
Elicio reports promising early results in cancer vaccine trial By Investing.com - Investing.com Australia
Elicio reports promising early results in cancer vaccine trial By Investing.com - Investing.com
Elicio Therapeutics launches public offering of stock and warrants By Investing.com - Investing.com India
Elicio Therapeutics launches public offering of stock and warrants - Investing.com
Elicio Therapeutics Shares Slip 28% After Public Offering, Drug Data - MarketWatch
Form 424B5 Elicio Therapeutics, - StreetInsider.com
SEC Form 424B5 filed by Elicio Therapeutics Inc. - Quantisnow
Elicio Therapeutics’ Promising Early Results in Cancer Vaccine Trial - TipRanks
Elicio Therapeutics Announces Proposed Public Offering - ForexTV.com
Elicio Therapeutics shares are trading lower after the company announced preliminary disease-free survival analysis ... - Quantisnow
Elicio Therapeutics Announces Proposed Public Offering - GlobeNewswire
Elicio Therapeutics Announces Proposed Public Offering - GlobeNewswire Inc.
Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing ... - The Bakersfield Californian
Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a ... - GlobeNewswire
Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a ... - Yahoo Finance
Elicio Therapeutics Announces Proposed Public Offering - Yahoo Finance
Elicio Therapeutics Inc (ELTX) 財務データ
収益
当期純利益
現金流量
EPS
0.05%
4.86%
大文字化:
|
ボリューム (24 時間):